EHL Stem Cell Service Centre
Disease information and regenerative-medicine approaches from EHL BIO Korea
Explore conditions covered in EHL BIO's published information, its cell technology and GMP manufacturing system, then send your medical history for assessment by the hospital in Seoul.
Korean regenerative-medicine law
Korea provides a regulated advanced regenerative-medicine treatment pathway
Korea's amended law, effective 21 February 2025, allows designated advanced regenerative-medicine institutions to submit treatment plans for committee review and charge for treatment delivered under a plan found suitable.
The law does not automatically authorise every stem-cell type for every disease. Access depends on the institution's status, cell type, condition, a suitable reviewed plan and individual patient assessment.
Browse by body system
Only categories with direct disease information published by EHL BIO are shown.
Conditions covered by EHL BIO
11 topics from EHL BIO's CURE collection, each linked to its original source.
EHL BIO information and approach
Diabetes
EHL BIO presents diabetes as an area of regenerative-medicine interest, focusing on the relationship between metabolic function, circulation and tissue recovery.
Explore EHL's approach
EHL BIO information and approach
Alzheimer's Disease & Dementia
EHL BIO presents its research interest in the interaction between stem cells, amyloid accumulation and the neurological environment in Alzheimer's disease.
Explore EHL's approach
EHL BIO information and approach
Degenerative Osteoarthritis
EHL BIO presents degenerative arthritis as a regenerative-medicine area centred on cartilage, inflammation and joint function.
Explore EHL's approach
EHL BIO information and approach
Chronic Obstructive Pulmonary Disease
EHL BIO presents chronic obstructive pulmonary disease as a research area involving inflammation and damaged lung tissue.
Explore EHL's approach
EHL BIO information and approach
Liver Cirrhosis
EHL BIO presents liver cirrhosis as a regenerative-medicine area focused on liver-cell support, inflammation and fibrosis.
Explore EHL's approach
EHL BIO information and approach
Myocardial Infarction
EHL BIO presents myocardial infarction as a regenerative-medicine area involving damaged heart muscle and vascular support.
Explore EHL's approach
EHL BIO information and approach
Autoimmune Disease
EHL BIO presents autoimmune disease as an area of interest for the immune-modulating characteristics of adult stem cells.
Explore EHL's approachEHL BIO information and approach
Rheumatoid Arthritis
EHL BIO includes rheumatoid arthritis within its autoimmune-disease information, focusing on immune balance and the immune-modulating characteristics of adult stem cells.
Explore EHL's approach
EHL BIO information and approach
Atopic Dermatitis
EHL BIO develops ADSTEM, an autologous adipose-derived stem-cell programme for moderate-to-severe atopic dermatitis, alongside its published clinical-development updates.
Explore EHL's approach
EHL BIO information and approach
Erectile Dysfunction
EHL BIO presents erectile dysfunction as a regenerative-medicine area involving vascular and tissue function.
Explore EHL's approach
EHL BIO information and approach
Chronic Kidney Disease
EHL BIO is developing KDSTEM Inj., an autologous urine-derived stem-cell therapy for chronic kidney disease; Korea's MFDS approved its Phase 1 clinical-trial plan in May 2023.
Explore EHL's approachBegin with an individual assessment
Send your history, test results and goals. The hospital team can review them and explain the relevant pathway in Korea.